VTGN

Vistagen Therapeutics Inc

0.2577

+0.0247+10.60%

Opening13:23 09/22 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.2428/0.2330

TODAY RANGE0.2407-0.2633

VOL4.52M

MARKET CAP11.44M

52 WEEK RANGE0.1980-5.14

AVG VOL (3M)3.89M

% TURNOVER10.19%

TURNOVER--

P/E (TTM)-0.1535

% RANGE9.70%

EPS(TTM)-1.6783

P/E(FORWARD)-0.1777

P/B0.4671

BVPS0.5517

DIVIDEND--

P/S8.05

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP11.39M

SHARES OUTSTANDING44.38M

NEXT EARNINGS11/11-11/16

FREE FLOAT44.21M

LOT SIZE1

EX-DATE06/07/2023

News

Press Releases

Financial Reports

Profile

NASDAQ·2h ago
Vistagen Reports Preliminary Data From Fasedienol Phase 3 Extension Study; Stock Up
TipRanks·4h ago
Vistagen announces preliminary data from OLE of Palisade-4 Phase 3 study
TipRanks·09/11 10:31
VistaGen Stockholders Reaffirm Board, Governance and Oversight
TipRanks·09/01 09:34
Vistagen Therapeutics Lawsuit: Company Seeks Dismissal of Investor Securities Claims
NASDAQ·08/14 16:36
Vistagen Reports Narrower Q1 Loss; Plans FDA Meeting On Fasedienol Development Path
Dow Jones·08/14 12:38
*Vistagen Therapeutics: Current Resources Not Sufficient to Extend Cash Runway for More Than a Year >VTGN
Dow Jones·08/14 12:38
*Vistagen Therapeutics: Runway To Fund Operations Into 2027 >VTGN
Seeking Alpha·08/14 12:33
VistaGen Therapeutics GAAP EPS of -$0.30 beats by $0.06, revenue of $1.48M beats by $1.31M
Dow Jones·08/14 12:33
*Vistagen Therapeutics 1Q Rev $1.48M >VTGN
Dow Jones·08/14 12:32
Press Release: Vistagen Reports Fiscal Year 2027 -2-
Dow Jones·08/14 12:32
Press Release: Vistagen Reports Fiscal Year 2027 First Quarter Financial Results and Corporate Update
TipRanks·08/06 21:36
VistaGen reports Phase 2 fasedienol trial topline results
TipRanks·08/06 15:50
Analysts’ Opinions Are Mixed on These Healthcare Stocks: VistaGen Therapeutics (VTGN), Iovance Biotherapeutics (IOVA) and Aurinia Pharmaceuticals (AUPH)
TipRanks·08/06 13:45
Vistagen announces topline results from fasedienol repeat dose study
TipRanks·08/04 18:00
SRX Global (NYSE American: SRXH) Acquires Stake in Vistagen Therapeutics

Same Industry

Name/Symbol

Change%

Price

VTGN

Regeneron Pharmaceuticals

REGN

-0.58%

784.85

GridAI Tech

GRDX

+9.32%

3.400

BNTX

United Therapeutics Corp.

UTHR

+0.65%

496.31

Siga Technologie

SIGA

+2.95%

3.140

Vertex Pharmaceuticals Inc

VRTX

-1.55%

508.34

Moderna

MRNA

-2.55%

154.04

CRL

MEDP

TLPH

ICON plc

ICLR

-3.28%

164.11

CBPO

Iqvia Hldgs Inc

IQV

+1.30%

269.88

MOLN

ARCT

PRAH

Gilead Sciences Inc

GILD

-0.52%

150.11

Incyte Corp

INCY

-1.81%

125.31

APVO

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.